- Home
- QGEN vs SOLS Comparison
QGEN vs SOLS Comparison
Compare QGEN & SOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QGEN | SOLS |
|---|---|---|
| Founded | 1986 | 2025 |
| Country | Netherlands | United States |
| Employees | N/A | 4400 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Aerospace |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.7B | 9.6B |
| IPO Year | 1998 | N/A |
Fundamental Metrics
Financial Performance| Metric | QGEN | SOLS |
|---|---|---|
| Price | $43.84 | $60.50 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 4 |
| Target Price | $45.76 | ★ $79.25 |
| AVG Volume (30 Days) | 2.2M | ★ 3.5M |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | ★ 7.17% | 0.39% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.18 | $6.36 |
| Revenue Next Year | $5.71 | $5.64 |
| P/E Ratio | ★ $24.01 | $54.31 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $32.53 | $40.43 |
| 52 Week High | $57.82 | $90.80 |
Technical Indicators
Market Signals| Indicator | QGEN | SOLS |
|---|---|---|
| Relative Strength Index (RSI) | 68.74 | 42.22 |
| Support Level | $42.82 | $55.04 |
| Resistance Level | $44.03 | $62.52 |
| Average True Range (ATR) | 0.85 | 2.77 |
| MACD | 0.03 | 1.05 |
| Stochastic Oscillator | 85.92 | 60.99 |
Price Performance
Historical ComparisonAbout QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).
About SOLS Solstice Advanced Materials Inc.
Solstice Advanced Materials is a diversified specialty chemicals company created in late 2025 after being spun off from Honeywell. It sells chemicals and materials to a wide range of end markets. Its largest product category is refrigerants used in heating, ventilation and air conditioning systems, and autos, where Solstice sells low global warming potential refrigerants. The company also sells materials used for building and construction, semiconductor production, healthcare packaging, and defense. Additionally, Solstice runs the only US uranium conversion business currently in operation.